TR BioSurgical Launches TR-ClarifEYE™ For Dog Glaucoma
17 years ago
8363 views
Posted
29th October, 2009 00h00
R ClarifEYE™ is a new, patented medical device that is implanted within the eye to recreate appropriate fluid outflow. An ongoing study in dogs has shown the implant to help maintain pressure for over one year in the majority of patients treated. The device is available to veterinarians around the world and is sold exclusively by TR BioSurgical, LLC.
About TR BioSurgical, LLC TR BioSurgical is a privately held veterinary company developing a range of biomaterials and devices for tissue repair and regenerative medicine. TR BioSurgical has specific interests in ophthalmology, dermatology, and orthopedics including cartilage repair. TR BioSurgical has one osteopromotive scaffold to market, TR Matrix™, for use in companion animals for bone repair. The company has a strong pipeline of advanced medical device technologies under development.More from
- Dignipets expands mobile end-of-life veterinary care into Plymouth and Exeter
- Vets Now marks 25 years with Pet Emergency Week campaign
- VDS launches VetResolve to help practices meet new complaints handling requirements
- Ronda.vet links locum shifts to CPD rewards in UK veterinary first
- Cancellations have been damaging locum work for years but no-one was keeping count - now Ronda is

3 days ago